Glycaemic control after treatment intensification in patients with type 2 diabetes uncontrolled on two or more non‐insulin antidiabetic drugs in a real‐world setting

To assess glycaemic control after treatment intensification in patients with type 2 diabetes uncontrolled on ≥2 non‐insulin antidiabetic drugs (NIADS).

[1]  L. Smeeth,et al.  Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink , 2018, BMC Medicine.

[2]  Eric L. Johnson,et al.  Cardiovascular Disease and Risk Management: Review of the American Diabetes Association Standards of Medical Care in Diabetes 2018 , 2018, Annals of Internal Medicine.

[3]  K. Khunti,et al.  Comparison of glucose‐lowering agents after dual therapy failure in type 2 diabetes: A systematic review and network meta‐analysis of randomized controlled trials , 2018, Diabetes, obesity & metabolism.

[4]  Frank B. Hu,et al.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications , 2018, Nature Reviews Endocrinology.

[5]  M. Gratacós,et al.  Therapeutic inertia in patients treated with two or more antidiabetics in primary care: Factors predicting intensification of treatment , 2018, Diabetes, obesity & metabolism.

[6]  K. Khunti,et al.  Identification of barriers to insulin therapy and approaches to overcoming them , 2017, Diabetes, obesity & metabolism.

[7]  K. Khunti,et al.  Clinical inertia versus overtreatment in glycaemic management. , 2017, The lancet. Diabetes & endocrinology.

[8]  K. Khunti,et al.  Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second‐line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany , 2017, Diabetes, obesity & metabolism.

[9]  G. Rutten,et al.  Overtreatment of older patients with type 2 diabetes mellitus in primary care , 2017, Diabetes, obesity & metabolism.

[10]  Pharmacologic Approaches to Glycemic Treatment : Standards of Medical Care in Diabetes d 2018 , 2017 .

[11]  W. Polonsky,et al.  Understanding the Gap Between Efficacy in Randomized Controlled Trials and Effectiveness in Real-World Use of GLP-1 RA and DPP-4 Therapies in Patients With Type 2 Diabetes , 2017, Diabetes Care.

[12]  W. Polonsky,et al.  Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control , 2017, Diabetes Care.

[13]  K. Khunti,et al.  Clinical inertia to insulin initiation and intensification in the UK: A focused literature review. , 2017, Primary care diabetes.

[14]  D. Mauricio,et al.  Is diabetes mellitus correctly registered and classified in primary care? A population-based study in Catalonia, Spain. , 2016, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion.

[15]  D. Mauricio,et al.  Glycaemic control and antidiabetic treatment trends in primary care centres in patients with type 2 diabetes mellitus during 2007–2013 in Catalonia: a population-based study , 2016, BMJ Open.

[16]  Jeffrey S. Gonzalez,et al.  Psychosocial factors in medication adherence and diabetes self-management: Implications for research and practice. , 2016, The American psychologist.

[17]  G. Pacini,et al.  Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus , 2016, Endocrine reviews.

[18]  Sei J. Lee,et al.  Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes. , 2016, JAMA.

[19]  Lena Osterhagen,et al.  Multiple Imputation For Nonresponse In Surveys , 2016 .

[20]  E. Huang,et al.  Glycemic Control in Older Adults With Diabetes Mellitus. , 2015, JAMA.

[21]  J. Fernández-Real,et al.  Older type 2 diabetic patients are more likely to achieve glycaemic and cardiovascular risk factors targets than younger patients: analysis of a primary care database , 2015, International journal of clinical practice.

[22]  K. Khunti,et al.  Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes , 2015, Cardiovascular Diabetology.

[23]  Gyusang Han.  Analysis of Consumption Status of Cooked Rice with Different Grains and Related Factors in a Korean Population : Based on Data from 2011 Korean National Health and Nutritional Examination Survey (KNHANES) , 2014 .

[24]  T. Bailey.  Options for combination therapy in type 2 diabetes: comparison of the ADA/EASD position statement and AACE/ACE algorithm. , 2013, The American journal of medicine.

[25]  Hae-Ra Han,et al.  Sex differences in the association between socio-economic status and type 2 diabetes: data from the 2005 Korean National Health and Nutritional Examination Survey (KNHANES). , 2013, Public health.

[26]  S. Inzucchi,et al.  Erratum to: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) , 2013, Diabetologia.

[27]  B. Bolibar,et al.  [SIDIAP database: electronic clinical records in primary care as a source of information for epidemiologic research]. , 2012, Medicina clinica.

[28]  D. Matthews,et al.  Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach , 2012, Diabetes Care.

[29]  D. Mauricio,et al.  Control of Glycemia and Cardiovascular Risk Factors in Patients With Type 2 Diabetes in Primary Care in Catalonia (Spain) , 2012, Diabetes Care.

[30]  Patrick Royston,et al.  Multiple imputation using chained equations: Issues and guidance for practice , 2011, Statistics in medicine.

[31]  Daniel Prieto-Alhambra,et al.  Construction and validation of a scoring system for the selection of high-quality data in a Spanish population primary care database (SIDIAP). , 2011, Informatics in primary care.

[32]  H. Gerstein,et al.  The Effect of Oral Antidiabetic Agents on A1C Levels , 2010, Diabetes Care.

[33]  L. Berkman,et al.  Emotional Support and Survival after Myocardial Infarction , 1992, Annals of Internal Medicine.